Emerging Infectious Diseases (Jun 2023)

MERS-CoV‒Specific T-Cell Responses in Camels after Single MVA-MERS-S Vaccination

  • Christian Meyer zu Natrup,
  • Lisa-Marie Schünemann,
  • Giulietta Saletti,
  • Sabrina Clever,
  • Vanessa Herder,
  • Sunitha Joseph,
  • Marina Rodriguez,
  • Ulrich Wernery,
  • Gerd Sutter,
  • Asisa Volz

DOI
https://doi.org/10.3201/eid2906.230128
Journal volume & issue
Vol. 29, no. 6
pp. 1236 – 1239

Abstract

Read online

We developed an ELISPOT assay for evaluating Middle East respiratory syndrome coronavirus (MERS-CoV)‒specific T-cell responses in dromedary camels. After single modified vaccinia virus Ankara-MERS-S vaccination, seropositive camels showed increased levels of MERS-CoV‒specific T cells and antibodies, indicating suitability of camel vaccinations in disease-endemic areas as a promising approach to control infection.

Keywords